OR WAIT null SECS
The company will hold exclusive ownership of patents supporting a mini-tablet dispenser to accommodate the oral dispensing needs of patients.
Phillips-Medisize, a Molex company, announced it is entering into an agreement with an undisclosed global pharmaceutical company for exclusive ownership of patents supporting a mini-tablet dispenser to accommodate the oral dispensing needs of patients.
With this dispenser, a patient or caregiver will be able to count and dispense mini tablets in predetermined amounts from one to 20 tablets, and it supports tablets of approximately 2x2 mm to 2.3x2.3 mm dimensions, according to a Sept. 10, 2019 press release. The device also lets the user visually confirm the measured tablet count number before dispensing and is designed to minimize damage or crushing of the mini tablets during dispensing.
“Through its unique working principle, the mini-tablet dispenser will be valuable in pediatrics, geriatrics, and oncology where patients often require highly flexible oral dosing based on age, weight, and other variables,” said Matt Jennings, CEO and president, Phillips-Medisize, in the press release. “Furthermore, in smaller patient populations the option to flexibly count to combine incremental mini-tablet doses offers an advantage over preparing multiple fixed oral tablet dose strengths.”
The company plans to make the dispenser available to the pharmaceutical market in early 2020.